MHRA Class 4 Medicines Defect Information: NovoRapid FlexTouch 100units/ml and Saxenda FlexTouch 6mg/ml
Class 4 Medicines Defect Information: NovoRapid® FlexTouch® 100 units/ml and Saxenda® FlexTouch® (liraglutide) 6mg/ml (Novo Nordisk Limited) Drug alert number: EL (22)A/33 Date issued: 21 July 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Novorapid FlexTouch 100units/ml solution for injection in pre-filled pen (insulin [...]
The post MHRA Class 4 Medicines Defect Information: NovoRapid FlexTouch 100units/ml and Saxenda FlexTouch 6mg/ml appeared first on PSNC Website.
Recent Comments